ROMANIA: Interbrands to acquire Europharm from Glaxo Smith Kline | Progresiv

Interbrands Marketing & Distribution (Interbrands) signed an Agreement for the acquisition of Europharm Holding (Europharm) from Glaxo Smith Kline group (GSK). The transaction is subject to the approval of the Romanian Authorities and specifically the Romanian Competition Council. Until all the required approvals are secured, Europharm will continue to be managed exclusively as part of the GSK Group.

Europharm is one of the most important local drug distribution companies, active in Romania since 1994. Its main focus is on contributing to increasing access for patients to treatments, by means of a complex product portfolio, by national coverage and partnership with clients and suppliers.

Europharm will continue its mission to provide customers and patients with best health-care products available, by keeping high standards in supplying a wide range of pharmaceutical products. Provided the transaction receives the Regulators’ approvals, Europharm will add to its pharmaceuticals market experience and expertise the marketing, logistics and distribution skills of Interbrands.

“It is a big moment for Europharm Distribution, which stands now as one of the major pharmaceuticals distribution companies in Romania. Europharm Distribution plays an important role on the Romanian pharmaceuticals distribution market and for GSK business in Romania, so, in analysing Interbrands’ binding offer, GSK took into consideration the commitment of the buyer for business continuity and employees wellbeing”, said George Katzourakis, SVP Head Europe Area, GSK Pharma Europe.

“Interbrands is very excited by the prospects of working with the Europharm Team and boldly further developing the Company to become a leading pharma distribution company in Romania”, said Rand Sherif CEO of Interbrands.